Treace Medical Concepts Overview
- Year Founded
-
2013

- Status
-
Public
- Employees
-
227

- Stock Symbol
-
TMCI

- Investments
-
1
- Share Price
-
$9.82
- (As of Wednesday Closing)
Treace Medical Concepts General Information
Description
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
Contact Information
Website
www.treace.comCorporate Office
- 100 Palmetto Park Place
- Ponte Vedra Beach, FL 32081
- United States
Corporate Office
- 100 Palmetto Park Place
- Ponte Vedra Beach, FL 32081
- United States
Treace Medical Concepts Stock Performance
As of 12-Feb-2025, Treace Medical Concepts’s stock price is $9.82. Its current market cap is $612M with 62.2M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.82 | $10.00 | $3.92 - $15.97 | $612M | 62.2M | 389K | -$0.99 |
Treace Medical Concepts Financials Summary
As of 30-Sep-2024, Treace Medical Concepts has a trailing 12-month revenue of $203M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 335,510 | 734,691 | 1,259,431 | 911,000 |
Revenue | 202,861 | 187,118 | 141,838 | 94,419 |
EBITDA | (54,013) | (45,734) | (37,597) | (15,824) |
Net Income | (61,523) | (49,527) | (42,815) | (20,552) |
Total Assets | 212,924 | 251,907 | 159,024 | 140,821 |
Total Debt | 70,121 | 70,303 | 68,589 | 29,365 |
Treace Medical Concepts Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Treace Medical Concepts Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Treace Medical Concepts Comparisons
Industry
Financing
Details
Treace Medical Concepts Competitors (28)
One of Treace Medical Concepts’s 28 competitors is Paragon 28, a Formerly VC-backed company based in Englewood, CO.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Paragon 28 | Formerly VC-backed | Englewood, CO | ||||
Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
Alpha-Stim | Private Equity-Backed | Mineral Wells, TX | ||||
Corin Group | Private Equity-Backed | Cirencester, United Kingdom |
Treace Medical Concepts Patents
Treace Medical Concepts Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250017604-A1 | Osteotomy systems and techniques for treating metatarsal misalignment | Pending | 14-Jul-2023 | ||
US-20240277350-A1 | Apparatus, system, and method for patient-specific harvesting guide | Pending | 21-Feb-2023 | ||
US-20240282221-A1 | Apparatus, system, and method for patient-specific models | Pending | 17-Feb-2023 | ||
US-20240268966-A1 | Apparatus, system, and method for lapidus correction | Pending | 11-Feb-2023 | ||
US-20240307076-A1 | Pinning and drilling instruments for small bone implant placement | Pending | 08-Feb-2023 | A61B17/1775 |
Treace Medical Concepts Signals
Treace Medical Concepts Investments (1)
Treace Medical Concepts’s most recent deal was a Corporate Asset Purchase with RedPoint Medical 3D (Patient Specific Instrumentation Technology) for . The deal was made on 12-Jun-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
RedPoint Medical 3D (Patient Specific Instrumentation Technology) | 12-Jun-2023 | Corporate Asset Purchase | Surgical Devices |
Treace Medical Concepts ESG
Risk Overview
Risk Rating
Updated November, 14, 2023
27.84 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile

Healthcare
Industry
of 587
Rank
Percentile

Medical Devices
Subindustry
of 199
Rank
Percentile

Treace Medical Concepts FAQs
-
When was Treace Medical Concepts founded?
Treace Medical Concepts was founded in 2013.
-
Where is Treace Medical Concepts headquartered?
Treace Medical Concepts is headquartered in Ponte Vedra Beach, FL.
-
What is the size of Treace Medical Concepts?
Treace Medical Concepts has 227 total employees.
-
What industry is Treace Medical Concepts in?
Treace Medical Concepts’s primary industry is Surgical Devices.
-
Is Treace Medical Concepts a private or public company?
Treace Medical Concepts is a Public company.
-
What is Treace Medical Concepts’s stock symbol?
The ticker symbol for Treace Medical Concepts is TMCI.
-
What is the current stock price of Treace Medical Concepts?
As of 12-Feb-2025 the stock price of Treace Medical Concepts is $9.82.
-
What is the current market cap of Treace Medical Concepts?
The current market capitalization of Treace Medical Concepts is $612M.
-
What is Treace Medical Concepts’s current revenue?
The trailing twelve month revenue for Treace Medical Concepts is $203M.
-
Who are Treace Medical Concepts’s competitors?
Paragon 28, Orthofix International, Spine Wave, Alpha-Stim, and Corin Group are some of the 28 competitors of Treace Medical Concepts.
-
What is Treace Medical Concepts’s annual earnings per share (EPS)?
Treace Medical Concepts’s EPS for 12 months was -$0.99.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »